Text Size

Danish Quality Assurance Project on Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (COPD) in Outpatient Lung Clinics

This study has been completed.
Sponsor:
Information provided by:
Boehringer Ingelheim Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00268866
First received: December 22, 2005
Last updated: April 15, 2008
Last verified: April 2008
History of Changes
  Purpose

Danish Quality Assurance Project on Diagnosis and Treatment of COPD in Outpatient Lung Clinics


Condition Intervention Phase
Pulmonary Disease, Chronic Obstructive
 Behavioral: Education
 Phase 4

Study Type: Observational
Official Title: Danish Quality Assurance Project on Diagnosis and Treatment of COPD in Outpatient Lung Clinics

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Boehringer Ingelheim Pharmaceuticals:

Primary Outcome Measures:
  • To optimise the diagnosis and treatment of COPD via a quality assurance project
  • Increase the knowledge and use of diagnostic tools and treatment options
  • Increase focus on COPD comorbidity

Estimated Enrollment: 1820
Estimated Study Completion Date: January 2007
Detailed Description:

Study Hypothesis:

Comparison(s):

none

  Eligibility

Ages Eligible for Study:   35 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Outpatient with the diagnosis or referral diagnosis of COPD.
  • COPD must be the primary reason for this outpatient contact (for both new patients and controls).

Exclusion Criteria:

  • Any co-morbidity that hampers the diagnosis and treatment of COPD in accordance with the COPD guidelines used locally (e.g. malignant disease, dementia or sequelae of apoplexy).
  • Asthma without the presence of COPD
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00268866

Sponsors and Collaborators
Boehringer Ingelheim Pharmaceuticals
Investigators
Study Chair: Boehringer Ingelheim Study Coordinator B.I. Denmark A/S
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00268866     History of Changes
Other Study ID Numbers: 205.367
Study First Received: December 22, 2005
Last Updated: April 15, 2008
Health Authority: Denmark: Danish Dataprotection Agency

Additional relevant MeSH terms:
Chronic Disease
Lung Diseases
Respiration Disorders
Pulmonary Disease, Chronic Obstructive
 Lung Diseases, Obstructive
Disease Attributes
Pathologic Processes
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on October 16, 2012